Suchergebnisse - "Sherlock, Sarah P"

PubPharm (40)

1

Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease : The NIMBLE Consortium

enthalten in: Radiology | 2023

von Fowler, K. | Venkatesh, S. | Obuchowski, N. | +17

CommentIn: Radiology. 2023 Oct;309(1):e232420. - PMID 37815446

2

Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis

enthalten in: Nature medicine | 2023

von Sanyal, A. | Shankar, S. | Yates, K. | +16

UpdateOf: Res Sq. 2023 Jan 19;:. - PMID 36711803

3

Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis : Results from a Phase 2 Trial

enthalten in: Rheumatology and therapy | 2023

von Østergaard, M. | Wu, J. | Fallon, L. | +5

4

Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial

enthalten in: Rheumatology and therapy | 2023

von Østergaard, M. | Wu, J. | Fallon, L. | +5

5

Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial

enthalten in: Rheumatology and therapy | 2023

von Østergaard, M. | Wu, J. | Fallon, L. | +5

6

Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial

enthalten in: Rheumatology and therapy | 2023

von Østergaard, M. | Wu, J. | Fallon, L. | +5

7

Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy

enthalten in: Scientific reports | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +8

8

Inter-Reader Consistency and Exclusionary Findings During Radiographic Screening for Phase 3 Trials of Tanezumab in Patients With Osteoarthritis

enthalten in: Osteoarthritis imaging | 2022

von Guermazi, A. | Roemer, F. | Kompel, A. | +10

9

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy : a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13

10

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13